# FDA Inspection 1168231 - Methodist Women's Hospital - April 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/methodist-womens-hospital/0e7101a7-7712-497e-9236-eb438d281a4e
Source feed: FDA_Inspections

> FDA Inspection 1168231 for Methodist Women's Hospital on April 28, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1168231
- Company Name: Methodist Women's Hospital
- Inspection Date: 2022-04-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1260055 - 2025-02-03](https://www.keypedia.com/records/fda_inspections/methodist-womens-hospital/e342f78f-2f25-417f-8d48-06227d66a835)
- [FDA Inspection 1260055 - 2025-02-03](https://www.keypedia.com/records/fda_inspections/methodist-womens-hospital/beb0eb37-7ff3-4f28-8fb9-5d68cf629335)
- [FDA Inspection 1168231 - 2022-04-28](https://www.keypedia.com/records/fda_inspections/methodist-womens-hospital/45a22831-ca89-4ed9-9b52-868b5b093555)
- [FDA Inspection 1061149 - 2018-07-10](https://www.keypedia.com/records/fda_inspections/methodist-womens-hospital/1509b57d-7aa8-4961-abce-bed13d9845ac)
- [FDA Inspection 957137 - 2016-01-26](https://www.keypedia.com/records/fda_inspections/methodist-womens-hospital/4aa83895-62ac-4744-bb65-b60e1adc69b7)

Company: https://www.keypedia.com/companies/methodist-womens-hospital/b3af725c-bafe-4248-b35b-e7ea263dfad5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d